NARB ProgramBackgrounds

National Advertising Review Board

The National Advertising Review Board (NARB) is the advertising self-regulation industry’s appellate body. Five-member NARB panels hear cases appealing an NAD or CARU decision and provide independent industry peer review, ensuring truthfulness and accuracy in national advertising and helping promote voluntary compliance of its decisions—a key pillar of industry self-regulation.  

Program Impact

NARB, established in 1971 as a fair and impartial appellate body, reviews appealed NAD or CARU decisions. Nominated by various leading organizations in the advertising industry, NARB members are selected for their stature and experience in their fields. 

Truth & Transparency

When a competitor’s advertising harms consumer trust or threatens a company’s reputation and market share, the advertising self-regulatory system creates a level-playing field for business and helps ensure consumers receive truthful and accurate advertising.

Compliance

After a decision, NARB or the challenger can check in on whether the advertiser has made appropriate modifications to its advertising and has 10 days to respond. The case is closed if there is a good faith effort to bring their advertising into compliance.

Non-Compliance

In cases of lack of good faith efforts to modify or discontinue advertising as a result of a NARB decision, NARB will refer the case to an appropriate government agency, usually the Federal Trade Commission (FTC).

Guidelines & Procedures


Any advertiser or challenger has the right to appeal NAD’s decision to NARB.  An advertiser has an automatic right of appeal. A challenger must request permission to appeal from the NARB chair and explain why it believes there is a substantial likelihood NARB would come to a different conclusion on a case than NAD. 

 

News & Blog

Press Release

BBB National Programs Announces 85 Distinguished Members of 2021 National Advertising Review Board Panel

McLean, VA – January 5, 2021 – BBB National Programs today announced the 2021 Panel Pool Members for its National Advertising Review Board, the appellate body for the U.S. advertising industry’s system of self-regulation. The National Advertising Review Board panel pool members, selected for their stature and experience in...
Read Press Release
Press Release

BBB National Programs Partners with Facebook to Strengthen Truth-in-Advertising Enforcement on the Social Network's U.S. Platform

New York, NY – December 2, 2020 – Taking an important step to advance the effectiveness of its quick and efficient self-regulatory programs, BBB National Programs today announced a new National Advertising Division (NAD) partnership with Facebook. 

Read the Press Release

Misleading Health Claims in COVID-19 Advertising

Feb 17, 2021, 09:56 AM by Laura Brett, Vice President, National Advertising Division
Consumers rely on ads, especially those that claim a product will support their immune system or help ward off disease. When they hear these claims, they also expect that there is science that supports such claims. Truth in advertising is important to protect consumers and help level the playing field for fair competition in the marketplace. This core concept becomes especially important when advertising health-related products, including over-the-counter drugs and dietary supplements.

During the COVID-19 pandemic, there has been an explosion of challenges to health product advertisements that expressly or impliedly claim to protect consumers and their families from the coronavirus. Consumers rely on ads, especially those that claim a product will support their immune system or help ward off disease. When they hear these claims, they also expect that there is science that supports such claims. 

Truth in advertising is important to protect consumers and help level the playing field for fair competition in the marketplace. This core concept becomes especially important when advertising health-related products, including over-the-counter drugs and dietary supplements. 

COVID-19 has forced consumers to focus on their health and well-being, so it is no surprise that health-related advertising has also been a focus of competitor challenges at BBB National Programs this past year. Indeed, there has been a nearly 50 percent increase in competitor challenges concerning health-related advertising claims.

For example, there were multiple challenges to products touting health and wellness benefits for traditional over-the-counter drugs, as well as natural alternatives that purported to offer similar relief or alternative wellness benefits. Brands new to self-regulation participated in challenges, including makers of essential oils and natural cough remedies, both popular products in the burgeoning natural health and wellness marketplace.  

 

 

Many of these product claims about wellness benefits required a review of complex issues and science-heavy claim substantiation, an encouraging indicator that brands take seriously the requirement that health-related advertising claims be supported by competent and reliable scientific evidence. The resulting decisions provide guidance on crafting truthful and accurate advertising for consumers so that health-related advertising claims are supported by science and competitors play by the same set of rules.    

BBB National Programs’ National Advertising Division (NAD) and Direct Selling Self-Regulatory Council (DSSRC) have monitored the advertising landscape for decades, but during the COVID-19 pandemic, health-related claims, including those referencing the coronavirus, represented the greatest volume of challenges and cases received. 

Once the pandemic began, government agencies sprang into action. Both the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have issued dozens of warning letters since spring 2020 about express and implied claims that products can treat or prevent COVID-19.  

As the effects of the pandemic continue, NAD and DSSRC remain vigilant, with each increasing their monitoring for advertising touting COVID-19-related health benefits due to its prevalence. During 2020, 38 percent of NAD’s monitoring cases were brought against companies making health-related claims concerning their product’s ability to boost consumers’ immunity against, or otherwise protect them from, COVID-19. After releasing guidance for the direct-selling industry early in the year that urged caution regarding health-related claims made by direct sellers or their salesforces, DSSRC saw 98 COVID-19 related cases, primarily on social media platforms and primarily related to the dietary supplement industry.  

Hope is on the horizon, with virus case counts and deaths going down, and COVID-19 vaccinations ramping up. BBB National Programs applauds the herculean efforts by researchers, producers, and regulators to get groundbreaking medical products – both preventative and for treatment – safely into the marketplace to combat the medical crisis.

The commitment we bring to this role is the same we’ve had for 50 years, to be champions for truth in advertising and ensure that consumers get truthful information about products that can support their health during this crisis

 

 

 

Decisions

Decision

NARB Recommends AT&T Disclose Material Connections When Citing Testing Company Data, Modify “Building 5G on America’s Best Network” Claim

A panel of the National Advertising Review Board (NARB) has recommended that AT&T Services, Inc. clearly and conspicuously disclose its material connection to Global Wireless Solutions (GWS) when making a “Best Network” claim that is based on GWS testing. The NARB panel also...

Read the Decision
Decision

NARB Recommends Comcast Discontinue or Modify “Best In-Home WiFi Experience” Claim and Discontinue its “Roommate” Commercial

A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, has recommended that Comcast Cable Communications, LLC d

Read Decision
Decision

NAD Recommends T-Mobile Modify Post-Merger 5G Claims to Avoid Implication that Aspirational Benefits are Imminently Available

New York, NY – February 23, 2021 – The National Advertising Division (NAD) recommended that T-Mobile, U.S., Inc. modify certain advertising claims that imply imminent availability of certain promoted benefits to T-Mobile customers as...

Read the Decision
Decision

NAD Recommends Nanoceutical Solutions Discontinue Certain Claims for Nano Glutathione Liquid Dietary Supplement and Modify Instagram Ad

The National Advertising Division (NAD) recommended that Nanoceutical Solutions discontinue efficacy and establishment claims for its Nano Glutathione liquid dietary supplement due to a failure to provide sufficient evidence for the claims. The claims at issue were challenged by the Council for...

Read Decision

 

 

 

Frequently Asked Questions

 

 

 

 

Contact Us

*Required fields